Friday, May 29, 2026

< + > Why Scaling Smart Hospitals is Harder Than it Looks — And What Actually Works

The following is a guest article by Alisha Moopen, Managing Director and Group CEO at Aster DM Healthcare

Every health system leader I speak with has a smart hospital pilot they’re proud of. A connected room that reduced response times. A virtual monitoring tool that caught deterioration early. An AI-assisted workflow that impressed the clinical team and made it onto a conference slide. What far fewer of them have is a second floor that looks like the first.

That gap — between a successful pilot and genuine enterprise-wide transformation — is the defining challenge of healthcare’s digital moment. And after years of scaling connected care across one of the Middle East and South Asia’s largest integrated healthcare networks, I can tell you: it is almost never a technology problem. The technology works. The scaling doesn’t — because scaling requires something harder than a good proof of concept. It requires a fundamental rethink of how care is designed, delivered, and coordinated.

The Pilot Trap

Pilots succeed in controlled conditions. They have dedicated champions, focused resources, and the benefit of novelty. Enterprise rollouts inherit none of those advantages. Different units have different workflows, different cultures, different patient mixes — and technology that was shaped around one environment rarely transplants cleanly into another. I’ve watched health systems deploy the same platform across ten facilities and get ten different results, not because the platform failed, but because the implementation assumed uniformity that didn’t exist.

The workforce dimension compounds this significantly. When digital tools are added to clinical workflows rather than integrated into them, they don’t save time — they consume it. Clinicians already managing documentation burden, alert fatigue, and staffing pressures don’t need another system to check. They need technology that works the way care works: continuously, collaboratively, and without friction. Getting that right requires involving clinical teams not as end-users of technology decisions, but as co-designers of them. In my experience, that shift — from deploying technology to co-designing it with clinical teams — is consistently where adoption outcomes diverge.

Technology as Infrastructure, Not Addition

The framing I keep returning to is this: smart hospital technology should be infrastructure, not an addition. When a virtual monitoring system’s data doesn’t flow directly into a clinician’s existing decision workflow, it becomes noise. When a connected room operates independently of the EHR, its value is isolated. When digital and physical care pathways are designed separately, you don’t have a smart hospital — you have a regular hospital with expensive equipment in it.

At Aster Hospital Al Qusais — recognized on Newsweek’s World’s Best Smart Hospitals 2025 list, and a two-time recipient of the Best Technology Use Case Award from the Healthcare Management Awards — we approached this from the outset, differently. Generative AI was embedded into patient treatment workflows to streamline and error-proof clinical processes, not bolted on as an afterthought. And rather than deploying point solutions, we built connectivity into the patient room itself: Talab, our inpatient interactive communication tool, links caregivers, clinical teams, administration, and housekeeping in a single seamless interface — so that the room itself becomes a coordination hub rather than a passive space. None of these were standalone deployments. They were designed as a connected ecosystem, each capability reinforcing the others, so that digital coordination became the default mode of care rather than a parallel track running alongside it.

Build for Integration from the Start

The health systems I see scaling fastest made one decision early that others didn’t: they treated integration as a design constraint from the beginning, not a problem to solve later. Retrofitting digital systems into physical and operational infrastructure that wasn’t built to receive them is expensive, slow, and organizationally punishing. Every new technology requires its own bespoke implementation effort. Every workflow redesign happens after the fact. The compounding advantage goes to systems that are built with integration in mind — where each new capability layers onto a foundation designed to support it.

This matters practically as well as philosophically. Implementation costs for enterprise-scale health IT are significant, and organizations that absorb them repeatedly — because each deployment is effectively a standalone project — are not building smart hospitals. They are building costly patchworks that will eventually need to be rebuilt anyway.

The question I’d encourage health system leaders to ask isn’t “does this technology work?” The evidence that it works is abundant. The harder, more useful question is: “Does our infrastructure — physical, operational, and cultural — allow this technology to become the way we deliver care?” Systems that can answer yes to that question are the ones that move from pilots that impress to a transformation that sticks. That’s the difference that matters, and it starts well before the technology is ever switched on.

About Alisha Moopen

Alisha Moopen is Managing Director and Group CEO at Aster DM Healthcare, one of the largest integrated healthcare networks in the Middle East, operating 15 hospitals, 117 clinics, and 285 pharmacies across the UAE, Saudi Arabia, Oman, Kuwait, Bahrain, and Qatar.



< + > 9amHealth Raises $26M to Expand Into Chronic Conditions Driving the Majority of Employer Pharmacy Spend

After Generating More than $50M in Projected Medical and Pharmacy Savings Across Two Fortune 100 Employers, 9amHealth is Expanding Its AI-Driven Specialty Care Platform Beyond Cardiometabolic Care to Address the High-Cost Chronic Conditions that Account for Up To 70% of Employer Spend

9amHealth, a leading virtual specialty care platform, today announced $26 million in Series B funding led by Define Ventures, with new participation from SemperVirens VC, Catalio Capital Management, and NewHealth Ventures.

Since its founding, 9amHealth has rapidly emerged as a leader in virtual cardiometabolic care, partnering with large enterprise employers and leading pharmaceutical organizations to support people living with obesity, diabetes, hypertension, and hyperlipidemia. Through its integrated care model, which combines clinical protocols, labs, medication management, and continuous care, the company has delivered significant pharmacy cost savings amid rising demand for GLP-1 therapies while improving engagement and clinical outcomes.

Building on this foundation, 9amHealth has already developed the clinical infrastructure, care delivery model, and technology platform needed to manage complex, high-cost chronic conditions at scale. The new funding will support continued growth as the company expands its platform to address additional high-cost, specialty-level chronic conditions, which collectively account for up to 70% of employer pharmacy spend.

These conditions often require ongoing specialty medications, repeat interventions, and coordinated care, which represents the largest and fastest-growing portion of employer healthcare spend.

“What makes this possible is our ability to combine specialized clinical care with AI-enabled clinical workflows and personalized member experiences that allow us to scale efficiently across complex chronic conditions,” said Frank Westermann, Co-Founder and CEO at 9amHealth. “We’ve already proven this model in cardiometabolic care, and are now extending to a much broader set of high-cost needs.”

The Series B round was led by Lynne O’Keefe, Founder and Managing Partner at Define Ventures, who will join the company’s Board of Directors.

“We’re proud to partner with 9amHealth at this pivotal stage,” said Lynne O’Keefe. “They’ve demonstrated strong clinical outcomes and cost savings in one of the fastest-growing categories in healthcare. Their platform has the potential to transform how employers manage their most expensive populations.”

About 9amHealth

9amHealth is an AI-enabled virtual specialty care platform focused on managing high-cost chronic conditions at scale. The company partners with employers, health plans, and pharmacy benefit managers to deliver comprehensive, cost-effective medical care for individuals living with obesity, diabetes, hypertension, and dyslipidemia. Members receive access to specialized clinicians, including endocrinologists, obesity medicine specialists, and clinical pharmacists, at-home lab testing, prescription medications, and lifestyle support.

9amHealth was founded in 2021 and is backed by leading healthcare investors like Define Ventures, SemperVirens VC, 7Wire Ventures, and The Cigna Group Ventures.

Learn more at join9am.com.

Originally announced May 13th, 2026



Thursday, May 28, 2026

< + > AdvancedMD’s New eMAR Fills Gap in Behavioral Health

Behavioral health doesn’t get enough funding or attention from us in healthcare. That’s why AdvancedMD‘s recent launch of an eMAR (electronic medication administration record) designed explicitly for this space is worth a closer look.

Healthcare IT Today sat down on camera with David Wilson, Vice President of Business Development at AdvancedMD, to discuss the origin of this new solution, how it fills a critical gap for mental health practices, and where the market is heading next.

Core Insight: As behavioral health practices bring intensive outpatient programs in-house to combat compressing reimbursements, they require specialized, point-of-care medication administration tools to remain compliant and profitable.

Filling the Point-of-Care Gap

In a typical outpatient setting, a prescription is written, and the patient fulfills the script at a pharmacy. However, for partial hospitalization or intensive outpatient programs, especially those offering medication-assisted treatment for substance use disorders, medication is often administered on-site, right at the point of care. This requires rigorous inventory tracking and DEA compliance reporting for controlled substances.

“eMAR is something that is really table stakes and a requirement for behavioral health groups who are engaging in certain types of programs,” explained Wilson. AdvancedMD recognized this specific gap in their otherwise robust behavioral health portfolio and built the eMAR as a fully integrated, modular component to help their clients successfully run these specialized programs.

Following the Shift to In-House Behavioral Health

The decision to build this solution was a strategic response to customer needs and not just about rounding out a product suite. Following a 2023 CMS policy change that opened up reimbursements for intensive outpatient programs, more behavioral health practices stopped referring patients out and started building these programs themselves.

Wilson noted, “We’re seeing more and more groups try to bring that service line or that business line in-house as a way to combat contraction in reimbursements and also as a way to provide better patient care.”

Fortunately, adopting the new tool isn’t a massive IT burden for these growing practices. “We don’t envision this being a multi-month implementation process,” shared Wilson. “We drop this in, and the practice now has the tools they need”.

What Healthcare IT Leaders Are Asking

How does a dedicated eMAR module impact our overall compliance and reporting posture? For organizations expanding into medication-assisted treatments, relying on makeshift tracking or standard EHR workarounds is a massive liability. A dedicated eMAR automates the heavy lifting of inventory tracking and regulatory reporting, specifically for closely monitored treatments. This reduces the administrative friction for clinical staff while ensuring the organization stays aligned with strict federal and state guidelines.

Does adding a new clinical module require a significant  retraining effort for the entire practice? Unlike core EHR replacements that disrupt an entire enterprise, modular eMAR rollouts are highly targeted. Because point-of-care medication administration is typically handled by a small, specific subset of clinical staff within a broader behavioral health practice, the technology only touches the people who actually need it. This focused implementation strategy accelerates adoption and keeps the broader organization focused on patient care without overwhelming the rest of the team.

Learn more about AdvancedMD at https://www.advancedmd.com/

Listen and subscribe to the Healthcare IT Today Interviews Podcast to hear all the latest insights from experts in healthcare IT.

And for an exclusive look at our top stories, subscribe to our newsletter and YouTube.

Tell us what you think. Contact us here or on Twitter at @hcitoday. And if you’re interested in advertising with us, check out our various advertising packages and request our Media Kit.



< + > When Lower Cost-to-Collect Fails to Improve Healthcare Organization Cash

The following is a guest article by Sid Mehta, President and Chief Growth Officer at Access Healthcare

Why yield is the difference between operating efficiently and getting paid correctly

Cost-to-collect is one of healthcare’s favorite metrics. Boards track it. CFOs benchmark it. Vendors build entire sales pitches around lowering it. And for good reason: knowing what it costs to run your revenue cycle is genuinely useful information.

Here is the problem nobody talks about enough. Many healthcare organizations improve cost-to-collect while cash performance quietly gets worse at the same time.

It’s not a rounding error. It’s a structural blind spot, and it is costing health systems real money.

A revenue cycle can operate cost-effectively and still lose millions in earned reimbursement through denials, underpayments, missed charges, authorization gaps, and unresolved patient balances. The organization may reduce the cost of performing the work yet still under-collect on earned revenue. Efficiency improved. Financial performance did not.

With margin pressure increasing across nearly every health system, organizations frequently prioritize aggressive operational cost reduction. While this focus is understandable, it stops short of the more important question: is the revenue cycle fundamentally protecting the revenue it was built to capture?

This is exactly where the distinction between cost-to-collect and cash-to-net patient revenue becomes worth understanding.

Cost-to-collect measures efficiency

Cost-to-collect measures the operational expense required to run the revenue cycle relative to total patient cash collections. The standard HFMA-aligned formula is straightforward:

Revenue cycle operating expense divided by total patient service cash collected.

Organizations rely on it because it is familiar, widely benchmarked, easy to communicate, and useful for identifying where administrative expense is running too high. Each of those considerations is valid.

However, cost-to-collect has a real limitation unreflective in the formula. It says almost nothing about whether the organization captured the reimbursement it was entitled to receive. It measures how inexpensively the work was completed. It does not measure whether the work protected the dollars at stake.

In today’s payer environment, this precise distinction matters more than it ever has.

The paradox healthcare leaders keep running into

The following scenario plays out more often than many organizations realize.

A hospital reduces billing costs by automating workflows, cutting staff, and shifting work to a lower-cost model. Operationally, it works. Cost-to-collect improves. Administrative expense declines. Productivity metrics look better on the dashboard.

At the same time, eligibility errors increase. Prior authorization gaps create payment delays. Underpayments go unreconciled. Denials sit longer before anyone follows up. Patient balances age without resolution.

So, the organization can say two things that are both completely true: our cost-to-collect improved, and our cash performance declined.

This illustrates the danger of optimizing efficiency focus metrics as a measure of performance. Efficiency asks how economically the work was completed. Financial performance asks whether the work protected and realized the revenue earned. Those are not the same question, and optimizing for one does not automatically improve the other.

Cash-to-net patient revenue measures whether you actually got paid

Cash-to-net patient revenue, commonly called yield, shifts the focus from operational cost to revenue realization. It measures actual cash collected against expected net revenue after contractual adjustments.

In plain terms: out of the revenue your organization realistically expected to receive, how much did you precisely collect?

Yield exposes things cost-to-collect cannot: denials, underpayments, authorization failures, documentation gaps, missed charges, and workflow leakage across the revenue cycle. And unlike efficiency metrics, yield cannot improve unless genuine financial performance improves. As a result, it serves as a much more reliable measure of whether the revenue cycle is functioning as intended.

“The industry is shifting from measuring administrative efficiency to measuring revenue realization,” said Sid Mehta, President and Chief Growth Officer. “Access Healthcare brings automation, operational expertise, and scale to move those numbers without overhauling what is already working.”

A simple example

Take a $100 claim. After contractual adjustments, the expected net reimbursement is $80.

In the first scenario, the organization collects the full $80. Yield is 100%.

In the second scenario, a denial reduces reimbursement to $76. Yield drops to 95%.

In the third scenario, multiple denials and rework reduce reimbursement to $68. Yield falls to 85%.

The charge did not change. The contract did not change. Operational execution changed. This is exactly what yield captures and what cost-to-collect never will: whether the revenue cycle delivered the dollars the organization earned.

Why this is a revenue defense problem

For years, most of the RCM market competed on operational efficiency. Lower labor costs. Offshore staffing. Transaction volume. Incremental automation. The messaging still dominates a lot of vendor conversations because cost reduction is easy to benchmark and easy to sell.

Seemingly running leaner does not automatically improve reimbursement performance. In most organizations, the bigger financial problem is not the administrative cost of processing claims. The bigger problem is the revenue disappearing through preventable leakage across the workflow.

Preventable denials. Incorrect payer reimbursement. Prior authorization gaps. Documentation inconsistencies. Delayed follow-up. Underpayment acceptance. Preventable write-offs resulting from process failure. Most of those losses do not appear in cost-to-collect. They appear in yield.

This is why revenue defense is becoming a more useful frame than operational efficiency for CFOs who want to understand where margin is going. Improving margins is not achieved by minimizing claims processing alone. You improve margins by protecting more of the revenue you truly earned.

When organizations improve documentation quality, reduce denials, strengthen authorization workflows, and identify underpayments before the window closes, two things happen at once: cash performance improves, and cost-to-collect often improves naturally as rework declines. Effectiveness drives efficiency. Chasing efficiency first rarely gets you to effectiveness.

What this means in practice

Healthcare organizations are entering a period where operational efficiency alone is not enough to sustain financial performance. Payer complexity keeps rising. Denial strategies keep evolving. Margins stay compressed. And AI adoption is accelerating on both sides of the transaction, with payers using their own automation to find reasons to reduce or deny payment faster than most provider teams can respond.

The organizations who can outperform in this environment will not necessarily be the ones processing claims at the lowest cost. They will be the ones capturing the highest percentage of the revenue they already earned through better workflow discipline, faster denial intervention, stronger authorization performance, more accurate reimbursement validation, and smarter automation built on top of stable operational foundations.

Cost-to-collect still matters. It is a legitimate operational benchmark and worth tracking. But if it is the primary lens your organization uses to evaluate revenue cycle performance, you are measuring the cost of the work without measuring whether the work is genuinely protecting your revenue.

Yield reveals this insight, and at present it is the more important metric.

About Access Healthcare

Access Healthcare delivers technology as a service, combining automation, analytics, and operational expertise to drive visible results. This summer, we’re introducing a new AI-Embedded RCM Operating Model focused on delivering smoother, cleaner workflows across the RCM cycle by utilizing the combination of AI, automation, and human expertise. If you’ll be at the HFMA Annual Conference, stop by booth #337 to talk more with us about the importance of Yield and how it can benefit your organization. If you’re not at the conference, reach out to us at Access Healthcare: https://www.accesshealthcare.com/about/contact



< + > Cross Country Healthcare to be Acquired by Knox Lane in All-Cash Transaction Valued at $437 Million

Cross Country Healthcare, Inc., a leading, technology-driven healthcare workforce solutions company, today announced that it has entered into a definitive agreement to be acquired by Knox Lane, a growth-oriented investment firm. Under the terms of the agreement, Knox Lane will acquire all outstanding shares of Cross Country Healthcare common stock for $13.25 per share in an all-cash transaction valued at $437 million. The transaction represents a premium of approximately 31 percent to Cross Country Healthcare’s closing price on May 6, 2026, and a 45 percent premium to the Company’s volume-weighted average trading price for the 90-day period ended May 6, 2026.

Upon completion of the transaction, Cross Country Healthcare will become a privately held platform company in Knox Lane’s portfolio and will cease trading on the Nasdaq stock exchange.

“We are excited to be working with Knox Lane, who brings significant and direct expertise in our sector to help Cross Country Healthcare enter its next phase of growth, while delivering significant and immediate value to our stockholders,” said Kevin Clark, Co-Founder, Chairman, and Chief Executive Officer at Cross Country Healthcare. “Knox Lane truly appreciates our iconic brand and the strength of our platform, especially the proprietary technology we’ve built on four decades of real‑world experience. That foundation uniquely positions organizations to design, predict, and optimize labor strategies with market‑leading precision. Just as important, Knox Lane recognizes the exceptional team behind it all, delivering best‑in‑class solutions to our clients and the thousands of professionals we proudly support every day,” he continued.

“Cross Country Healthcare is a longstanding leader and innovator in healthcare workforce solutions, with an unparalleled focus on delivering clinical excellence,” said John Bailey, Managing Partner at Knox Lane, and Shamik Patel, Partner at Knox Lane. “We are excited to leverage our extensive experience to bring added strategic focus and capabilities to the business to build on its already strong foundation, technology, and customer relationships.”

Transaction Details

The proposed transaction is expected to close in the third quarter of 2026, subject to customary closing conditions, including approval by Cross Country Healthcare stockholders and required regulatory approvals.

Upon completion of the transaction, the Company will continue to operate under the Cross Country Healthcare name and brand.

Additional details regarding the transaction will be included in a Current Report on Form 8-K to be filed by Cross Country Healthcare with the U.S. Securities and Exchange Commission (SEC).

Advisors

BofA Securities, Inc. is serving as exclusive financial advisor to Cross Country Healthcare, and Davis Polk & Wardwell LLP is serving as legal counsel. MTS Health Partners is serving as the exclusive financial advisor to Knox Lane, and Kirkland & Ellis LLP is serving as its legal counsel.

About Cross Country Healthcare, Inc.

Cross Country Healthcare, Inc. is a technology-driven healthcare workforce solutions company, delivering an AI-powered digital platform and advisory services backed by 40 years of healthcare labor expertise to help health systems optimize and sustain their entire labor ecosystem.

Through Intellify, its cloud-based workforce and vendor management platform designed to integrate with core hospital systems, Cross Country helps improve transparency across the labor ecosystem. Intellify unifies workforce management across service lines, including non-clinical, nursing, allied health, and locums, into a single, centralized view of internal and contingent labor. Powered by real-time analytics and AI-driven insights, the platform helps leaders forecast demand, optimize labor utilization, streamline workflows, and improve cost efficiency while supporting high-quality care delivery.

About Knox Lane

Based in San Francisco, Knox Lane is a growth-oriented investment firm comprised of a team of accomplished investors and operators with a shared work history and a strong track record of partnering with leading companies to accelerate transformational growth. Knox Lane employs an investor-operator mindset and seeks to provide support across a number of business components, including human capital, brand management, AI & end-to-end digital transformation, sourcing, supply chain and logistics, strategic acquisitions, and business development. For more information, please visit knoxlane.com.

Originally announced May 6th, 2026



Wednesday, May 27, 2026

< + > Making AI and Value-Based Care Work in Rural Health Facilities

Everyone knows that rural health care systems are stressed: costly populations, low reimbursements, staffing shortages, transportation problems—and the 900 billion to one trillion dollar cuts upcoming in Medicaid will severely add to those stresses. But rural providers also have advantages when it comes to the chances for transformation. In a recent video interview, we explore the opportunities in rural health, particularly the use of technology for value-based care with Pranam Ben, Founder & CEO at The Garage and Brittany Sachdeva, COO at Cibolo Health.

Ben says that 60% of health care payments already have some form of value-based modifier built into it, and credits this with reducing costs in the U.S. from an expected 6 trillion dollars to 5 trillion.

Rural organizations are often exceptionally strong at primary care delivery, but Sachdeva points out a towering challenge to value-based care for rural health: some 50% to 65% of costs are incurred in other facilities outside the ones used by patients for primary care. Technology solutions such as cleaner, well-integrated data and better coordination are required to make value-based care work.

What Sachdeva found is that the most impactful value based care strategy is when it’s an extension of the care team while still keeping the provider relationship central. Using Garage-generated prioritization lists in the background allows care teams to focus on the right patients without disrupting the provider-patient relationship.

The reality is that what works in urban markets often does not work in rural communities due to unique challenges around access, affordability, transportation, awareness, and social determinants.  On the positive side, Ben says, rural providers are very committed and have a “strong fabric” in their communities and are very resilient. They are not focused on maximizing the number of encounters. Furthermore, according to Sachdeva, it may be easier to implement new workflows at a small facility where there’s easier coordination and the staff trusts their leadership.

Both interviewees say that the $50 billion recently earmarked for improving rural health care in the Rural Health Transformation Program (RHTP) comes at a critical moment as communities prepare for the impact of the upcoming Medicaid reductions. Ben and Sachdeva suggested that this funding creates a great opportunity to use these funds to modernize infrastructure, virtualize care delivery, automate workflows with AI, train the workforce, and better position rural communities for long-term sustainability.

Ben says that the principle is to “focus on the right patients at the right time.” Value-based care means more screening and early disease management.  Sachdeva also emphasized that these investments impact the entire continuum of care and that payer partners must actively be part of these efforts.  Great payer partners are the key to being successful in value-based care.

This requires integrated data that is turned into “actionable insights.” Payer and provider data must be better integrated, perhaps requiring support at the state level.  Providers are operating with lean teams and need “one version of the truth” to focus on the patients that matter most within VBC contracts.

On top of a strong data infrastructure, AI can look through millions of patient records to identify revenue opportunities. Sachdeva points out that wearable devices can produce more accurate interventions by learning each patient’s personal baseline, instead of depending on “just what the textbook says is normal.”

Getting “rural-relevant” contracts is also important. AI can help reduce the manual labor of dealing with many contracts at many payers.  One of the largest barriers to successful VBC participation in rural markets is having enough scale and having payer relationships structured appropriately for rural organizations.  Cibolo and The Garage partnered together to help rural health organizations really address these obstacles.  Through this collaboration, the BlazeLink Contract Compliance Agent was born.

In our interview, Pranam noted that contracts can now be consumed by the agent in approximately 0.25 seconds on average and analyzed against millions of records to identify revenue opportunities. Given rural facilities often operate on extremely narrow margins, even recovering a fraction of the typical 3–6% of compromised revenue can materially impact sustainability.

Sachdeva shared that AI is becoming a necessity, not a replacement for providers. The “people” aspect of care cannot be removed. These technology and AI tools though can reduce the operational burden rural facilities face around contract compliance and understanding reimbursement methodologies.

Learn more about what’s happening in rural health to address the challenges, making rural health’s value based care efforts successful, and how technology can help in these efforts in this interview with The Garage and Cibolo Health.

Learn more about The Garage: https://www.thegaragein.com/

Learn more about Cibolo Health: https://cibolohealth.com/

Listen and subscribe to the Healthcare IT Today Interviews Podcast to hear all the latest insights from experts in healthcare IT.

And for an exclusive look at our top stories, subscribe to our newsletter and YouTube.

Tell us what you think. Contact us here or on Twitter at @hcitoday. And if you’re interested in advertising with us, check out our various advertising packages and request our Media Kit.

The Garage is a proud sponsor of Healthcare Scene.



< + > This Week’s Health IT Jobs – May 27, 2026

It can be very overwhelming scrolling through job board after job board in search of a position that fits your wants and needs. Let us take that stress away by finding a mix of great health IT jobs for you! We hope you enjoy this look at some of the health IT jobs we saw healthcare organizations trying to fill this week.

Here’s a quick look at some of the health IT jobs we found:

If none of these jobs fit your needs, be sure to check out our previous health IT job listings.

Do you have an open health IT position that you are looking to fill? Contact us here with a link to the open position and we’ll be happy to feature it in next week’s article at no charge!

*Note: These jobs are listed by Healthcare IT Today as a free service to the community. Healthcare IT Today does not endorse or vouch for the company or the job posting. We encourage anyone applying to these jobs to do their own due diligence.



< + > Why Scaling Smart Hospitals is Harder Than it Looks — And What Actually Works

The following is a guest article by Alisha Moopen, Managing Director and Group CEO at Aster DM Healthcare Every health system leader I spea...